Отправить статью
EN
Адрес для писем
220006, г. Минск, ул. Ленинградская 6, кабинет 2
Телефон: +375 17 363-88-92
Эл.почта: medjournal@bsmu.by

Депрессивные расстройства и риск кардиоваскулярных событий

А. Ф. Пинчук УО «Белорусский государственный медицинский университет»
2015 №1 | Лекции
Аннотация
Список литературы
Скачать полнотекстовую статью
Несмотря на достижения современной медицины, сердечно-сосудистая патология продолжает занимать лидирующие позиции в структуре заболеваемости и смертности в развитых странах.
Ключевые слова:
депрессия, инфаркт миокарда (ИМ), сердечно-сосудистые заболевания (ССЗ), инвалидность, смертность
A. F. Pinchuk

Despite to high level in modern medicine, cardiovascular disease continues to occupy a leading position in the structure of morbidity and mortality in developed countries. The high frequency of associated cardiovascular pathology of depression, causes the relevance of studying this problem. This article focuses on the comorbidity of depression and myocardial infarction.

Keywords
depression, myocardial infarction (MI), cardiovascular disease (CVD), morbidity, mortality
  • 1. Ватутин, Н. Т. Депрессивные расстройства и хроническая сердечная недостаточность / Н. Т. Ватутин, Н. В. Калинкина, Е. В. Картамышева и др. // Украинский кардиологический журнал. – 2013. – Вып. 3. С. 117–124.
  • 2. Гафаров, В. В. Восьмилетнее изучение влияния депрессии на риск возникновения инфаркта миокарда в популяции мужчин 25–64 лет / В. В. Гафаров, И. В. Гагулин, А. В. Гафарова, Е. А. Громова // Терапевтический архив. – М., 2005. – № 9. – С. 60–64.
  • 3. Митьковская, Н. П. Психоэмоциональный статус и клинико-лабораторная характеристика больных инфарктом миокарда при наличии неблагоприятной кластеризации факторов риска / Н. П. Митьковская, О. А. Скугаревский, Т. В. Статкевич, В. Е. Супрун и др. // Медицинский журнал. – 2010. – № 1. – С. 58–62.
  • 4. Семиглазова, М. В. Особенности диагностики и терапии тревожно-депрессивных расстройств у пациентов с инфарктом миокарда / М. В. Семиглазова, В. Н. Краснов, Т. В. Довженко и др. // Журнал неврологии и психиатрии. С. С. Корсакова. – 2012. – Т. 112, № 11, вып. 2: Депрессия. – С. 91–95.
  • 5. Терещенко, С. Н. Депрессия после инфаркта миокарда: угроза или гибель? / С. Н. Терещенко, И. В. Жиров, Ю. А. Васюк, A. B. Лебедев // Кардиология. – 2007. – № 8. – С. 93–96.
  • 6. Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis / H. Clarke [et al.] // Psychological Medicine journal. – 2010. – Vol. 40. – P. 1767–1778.
  • 7. Association between depressive episode before first myocardial infarction and worse cardiac failure following infarction / C. Dickens [et al.] // JAMA. – 2005. – Vol. 12. – P. 523–534.
  • 8. Benyamini, Y. Depression and Anxiety Following Myocardial Infarction and Their Inverse Associations with Future Health Behaviors and Quality of Life / Y. Benyamini, U. Goldbourt // Psychosomatic Medicine. – 2013. – P. 218–223.
  • 9. Burg, M. Depression predicts elevated endothelin-1 in patients with coronary artery disease / M. Burg, E. Martens, D. Collins, R. Soufer // Psychosomatic Med. – 2011. – Vol. 13. – P. 22–29.
  • 10. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms / S. Bozzini [et al.] // Int. J. Mol. Med. – 2009. – Vol. 24. – P. 213–218.
  • 11. Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions / K. Larsen [et al.] // JAMA. – 2013. – Vol. 25. – P. 88–96.
  • 12. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease / M. Whooley [et al.] // JAMA. – 2008. – Vol. 16. – P. 2379–2388.
  • 13. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment / H. S. Lett [et al.] // Psychosomatic Medicine. – 2004. – Vol. 66(3). – P. 305–315.
  • 14. Effects of depression and anxiety symptoms on cardiac mortality following myocardial infarction: a 2-year follow-up/ SHHosseni [et al.] // Int. J. Psychiatry Clinical Practices. – 2011. –Vol. 15. – P. 91–96.
  • 15. Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers / M. Brain [et al.] // Behavior Immune. – 2008. – Vol. 22. – P. 493–502.
  • 16. Epidemiology and treatment of depression in patients with chronic medical illness / J. Wayne Katon [et al.] // Dialogues Clin Neurosci. – 2011. – Vol. 13. – P. 7–23.
  • 17. Faller, H., Angermann C. E. Depression in chronic heart failure: complication, risk factor or autonomous disease? / H. Faller, C. E. Angermann // Internist (Berl). – 2008. – Vol. 49, N 4.–P. 394–404.
  • 18. Genetics of human cardiovascular disease / O. Kathiresan [et al.] // J. Cellular. – 2012. – Vol. 16. – P. 1242–1257.
  • 19. Glassman, A. H. Sertraline treatment of major depression in patients with acute MI or unstable angina / A. H. Glassman // JAMA. – 2002. – Vol. 14. – P. 701–709.
  • 20. Greta, W. Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis / W. Greta [et al.] // Med Scienty Monit. – 2011. – Vol. 17. – P. 2015–214.
  • 21. Goldston, K, Baillie A. J. Depression and coronary heart disease: A review of the epidemiological evidence, explanatory mechanisms and management approaches / K. Goldston, A. J. Baillie // Clin Psychol Rev. – 2008. – Vol. 28. – P. 288–306.
  • 22. Halaris, A. Co-Morbidity between Cardiovascular Pathology and Depression: Role of Inflammation / A. Halaris // Inflammation in Psychiatry. – 2013. – Vol. 28. – P. 144–161.
  • 23. Illness representation after acute myocardial infarction: impact on in-hospital recovery / C. Cherrington [et al.] // Am. J. Crit. Care. – 2004. – Vol. 13. – P. 136–145.
  • 24. Is depression a problem in patients with chronic heart failure? B. Szygula-Jurkiewicz [et al.] // Pol. Arch. Med. Wewn. – 2008. – Vol. 118, № 1–2. – P. 52–56.
  • 25. Is there an association between depressive symptoms and coronary artery disease in Polish adult population? J. Piwoński [et al.] // Cardiology Pol. – 2013. – Vol. 6. – P. 214–125.
  • 26. Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant / A. Daniele [et al.] // In Vivo. – 2011. – Vol. 25, № 6. – P. 895–901.
  • 27. Jiang, W. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure / W. Jiang [et al.] // American Heart Journal. – 2008. – Vol. 156(3). – P. 437–44.
  • 28. McCaffery, J. M. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin / J. M. McCaffery [et al.] // Psychosomatic Medicine. – 2006. – Vol. 68, № 2. – P. 187–200.
  • 29. Miguel-Hidalgo, J. J. Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes / J. J. Miguel-Hidalgo [et al.] // J. Affect Disord. – 2011. – Vol. 132, № 3. – P. 422–431.
  • 30. Muntner, P. Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: A regards (reason for geographic and racial differences in stroke) study / P. Muntner [et al.] // J. Am CollCardiol. – 2012. – Vol. 16. – P. 291–312.
  • 31. Nielsen, T. J., Vestergaard M., Christensen B. Mental health status and risk of new cardiovascular events or death in patients with myocardial infarction: a populationbased cohort study / T. J. Nielsen, M. Vestergaard, B. Christensen // BMJ Open. – 2013. – Vol. 2. – P. 38–46.
  • 32. Plastiras, A., Korompelis P., Stefanadis C. Role of depression in heart failure – choosing the right antidepressive treatment / A. Plastiras, P. Korompelis, C. Stefanadis // Int. J. Cardiology. – 2010. – Vol. 140, № 1. – P. 12–18.
  • 33. Platelet functions in patients with depression / Parakh K. [et al.] // South Med J. – 2008. – Vol. 101. – P. 612–617.
  • 34. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis / Joost P. van Melle, Peter de Jonge, Titia A. Spijkerman // Psychosomatic Medicine. – 2013. – Vol. 66. – P. 814–22.
  • 35. Roncella A, One-year results of the randomized, controlled, shortterm psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial / A. Roncella [et al.] // Int. J. Cardiol. – 2013. – Vol. 10. – P. 132–139.
  • 36. Self-reported depressive symptoms, diagnosed depression and cardiac morbidity and mortality after myocardial infarction / Zuidersma M, Conradi H. J., van Melle J. P. // American Heart Journal. – 2013. – Vol. 17. – P. 167–174.
  • 37. Sorensen, C. Postmyocardial infarction mortality in relation to depression: a systematic critical review / C. Sorensen // Psychother Psychosom. – 2005. – Vol. 74. – P. 69–80.
  • 38. The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study / O. Bjerkeset, U. Romild // American Heart Journal. – 2011. – Vol. 41. – P. 345–52.
  • 39. The role of the 5-HTTLPR polymorphism of the serotonin transporter gene in the development of depression in patients with coronary heart disease / V. Golimbet [et al.] // Psychosomatic Medicine. – 2012. – Vol. 112. – P. 63–72.
  • 40. Tomoda, A. No interaction between serotonin transporter gene (5-HTTLPR) polymorphism and adversity on depressionamong Japanese children and adolescents / A. Tomoda [et al.] // BMC Psychiatry. – 2013. – Vol. 10. – P. 134–143.